ScholarLens Back to search
2004•Unpublished venueRequires access

Study of Alprostadil on acute cerebral infaretion

Tian Xian-xian

Open publisher page 0 citations

Abstract

Objective It is to observe the clinical curative effect of Alprostadil (Kaishi) on acute cerebral infarction.Methods Eighty-two patients with acute cerebra infarction were randomly divided into treatment group and control group. Forty-two patients in Kaishi group were given Alprostadil 10 μg intravenous drip once a day for 15 days. Forty patients in root of red-rooted salvia (Danshen) group were given Danshen 20 mL intravenous drop once a day for 15 days.Results The neurological function deficit scors (NFDSs) and total effective rate in Kaishi group after treatment were 8±7 and 93%. Those in Danshen group were 11±6 and 73%. Those before and after treatmnent and between the two groups were significant difference.Conclusion Kaishi is a more effective drug in treating acute cerebral infarction.

About this research paper

What this paper is about

Objective It is to observe the clinical curative effect of Alprostadil (Kaishi) on acute cerebral infarction.Methods Eighty-two patients with acute cerebra infarction were randomly divided into treatment group and control group. Forty-two patients in Kaishi group were given Alprostadil 10 μg intravenous drip once a day for 15 days. Forty patients in root of red-rooted salvia (Danshen) group were given Danshen 20 mL intravenous drop once a day for 15 days.Results The neurological function deficit scors (NFDSs) and total effective rate in Kaishi group after treatment were 8±7 and 93%. Those in Danshen group were 11±6 and 73%. Those before and after treatmnent and between the two groups were significant difference.Conclusion Kaishi is a more effective drug in treating acute cerebral infarction.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective It is to observe the clinical curative effect of Alprostadil (Kaishi) on acute cerebral infarction.Methods Eighty-two patients with acute cerebra infarction were randomly divided into treatment group and control group. Forty-two patients in Kaishi group were given Alprostadil 10 μg intravenous drip once a day for 15 days. Forty patients in root of red-rooted salvia (Danshen) group were given Danshen 20 mL intravenous drop once a day for 15 days.Results The neurological function deficit scors (NFDSs) and total effective rate in Kaishi group after treatment were 8±7 and 93%. Those in Danshen group were 11±6 and 73%. Those before and after treatmnent and between the two groups were significant difference.Conclusion Kaishi is a more effective drug in treating acute cerebral infarction.

Key concepts: Medicine, Anesthesia, Neurological deficit, Cerebral infarction, Salvia, Significant difference, Internal medicine, Traditional medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Study of Alprostadil on acute cerebral infaretion — Research Paper | ScholarLens